Inovio Pharmaceuticals Inc (INO)

[xlt leader]

Adam F has a site dedicated to exposing his slimy writing here:

http://www.exposeadam.com/



This website is devoted to providing a forum to rebut and correct the numerous one sided articles written by Adam Feuerstein on behalf of the Street.com. Adam Feuerstein has been writing for the Street.com since 2001 and is marketed as their Senior Columnist although he has never attended journalism school nor does he have any formal education in Journalism. In fact, he has NO formal science background either (he was a political science major at Emory University) and thus his credibility and objectivity as a biotech journalist must be questioned. He has been sued by biotech companies for his one sided attacks . Additionally, his inaccurate reporting has even led to patient safety issues as outlined in this article about Oculus Innovative Sciences. There have been numerous articles written about his one sided tactics and his questionable timing and release of misleading headlines that can be found here. Under the guise of being a biotech journalist, Adam frequently writes misleading headlines and articles that are widely disseminated via the Street.com's media network. Our Website is devoted to biotech investors to voice their rebuttals and critiques of Adam 's one sided articles. So you are free to use any information on this site for personal or commercial purposes, modify it or redistribute as long as you keep a link back to ExposeAdam .com with the content. We are always looking for tips about Adam 's Past, his relationships with anyone on wall Street and any possible unethical or illegal activities he may be involved in. Got Something to expose about Adam ? Submit your tip here. Don't Forget to leave comments for us on the bottom of the page. We look forward to your contributions to our site.

Look back soon for our own version of Expose Adam 's Biotech Weekly which will tell the other side of the story to Adam 's Weekly column and rebut the erroneous one sided sell side slant he uses to hurt the retail investors. Additionally, we will be opening a message board soon to openly discuss biotech stocks and any and everything Adam Feuerstein.